WINDTREE THERAPEUTICS INC /DE/ financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2025.

Symbol
WINT, WINTW on OTC
Location
Warrington, PA
Fiscal year end
31 December
Latest financial report
19 Nov 2025

Quick Takeaways

  • WINT - WINDTREE THERAPEUTICS INC /DE/ financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2025.
  • Headline metric: Return On Equity 1111%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-780%</span>.
  • Most recent SEC facts end date: 30 Sep 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-09-30) highlights Return On Equity 1110.8%, Return On Assets -172.3%, and Current Ratio 0.33x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

33.2/100

Weak Confidence medium

Return On Equity

1111%

Metric score 100.0/100

Return On Assets

-172%

Metric score 0.0/100

Financial Health

Current Ratio
0.33x
Debt to Equity
6.73x

Strengths

Return On Equity

Watchpoints

Return On Assets, Current Ratio, and Debt-to-equity

Key metrics snapshot

Return On Equity

1111%

YoY: -780%

Industry median: -47% (n=218)

View history

Return On Assets

-172%

YoY: +490%

Industry median: -44% (n=217)

View history

Current Ratio

0.33x

YoY: +21%

Industry median: 3.67x (n=218)

View history

Debt-to-equity

6.73x

YoY: +110%

Industry median: 0.31x (n=169)

View history

NetIncomeLoss YoY

-312%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity 1111% -780%
Return On Assets -172% +490%

Financial Health

Metric Latest value YoY change
Current Ratio 0.33x +21%
Debt-to-equity 6.73x +110%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -312%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 29,334,220 +4856%
Common Stock, Shares, Outstanding 33,634,220 +1337%
Common Stock, Value, Issued $34,000 +1600%
Weighted Average Number of Shares Outstanding, Basic 26,675,559 +150270%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $8,541,000 -50%
General and Administrative Expense $1,855,000 -33%
Operating Income (Loss) $33,497,000 -31%
Nonoperating Income (Expense) $10,005,000 -163%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $43,502,000 -351%
Income Tax Expense (Benefit) $3,508,000 -5041%
Earnings Per Share, Basic 44 +99%
Cash and Cash Equivalents, at Carrying Value $204,000 -91%
Assets, Current $7,205,000 +83%
Property, Plant and Equipment, Net $61,000 -52%
Operating Lease, Right-of-Use Asset $707,000 -38%
Assets $15,983,000 -48%
Accounts Payable, Current $1,651,000 -20%
Accrued Liabilities, Current $2,007,000 +22%
Liabilities, Current $21,901,000 +52%
Deferred Income Tax Liabilities, Net $1,643,000 -66%
Operating Lease, Liability, Noncurrent $240,000 -69%
Other Liabilities, Noncurrent $3,800,000 0%
Liabilities $27,584,000 +15%
Retained Earnings (Accumulated Deficit) $889,371,000 -4.8%
Stockholders' Equity Attributable to Parent $11,610,000 -363%
Liabilities and Equity $15,983,000 -48%
Common Stock, Shares Authorized 120,000,000 0%
Common Stock, Shares, Issued 33,634,221 +1337%
Common Stock, Par or Stated Value Per Share 0 0%
Operating Lease, Liability, Current $544,000 +16%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 4,970,680 -0.1%
Additional Paid in Capital $880,781,000 +2.9%
Preferred Stock, Shares Outstanding 0
Share-based Payment Arrangement, Expense $141,000 -81%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY